![]() Users of the Proclaim XR SCS system can also use Abbott’s NeuroSphere Virtual Clinic technology. “This new indication for Proclaim XR will drive meaningful change in the treatment of pain associated with diabetic peripheral neuropathy and will be an important tool for physicians and patients in managing this debilitating condition.”ĭPN is a complication of diabetes that is characterised by damage to the nerves running to the feet.Īccording to the company, nearly 50% of diabetic adult patients will develop DPN during their lifetime, with symptoms including pain and numbness in the legs, feet and hands.Ĭurrently, there are no disease-modifying treatments available for DPN, only symptom management and behavioural modifications to stop further nerve damage, which can be caused due to high glucose levels. Accessed January 27, 2023.They will then be able to control their therapy through an Apple device.Ībbott neuromodulation vice-president Pedro Malha said: “As a leader in diabetes care, Abbott is intimately familiar with the challenges people with diabetes encounter daily. ![]() “This new indication for Proclaim XR will drive meaningful change in the treatment of pain associated with diabetic peripheral neuropathy and will be an important tool for physicians and patients in managing this debilitating condition."įDA APPROVES ABBOTT'S SPINAL CORD STIMULATION FOR PEOPLE LIVING WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY. "As a leader in diabetes care, Abbott is intimately familiar with the challenges people with diabetes encounter daily,” Pedro Malha, vice president, neuromodulation, Abbott, said in the press release. Patients with DPN who are interested in the SCS system can be referred to a spine surgeon or pain management specialist by their health care provider. The safety and dose-response curves of each dose is not clinically established. Further, patients can work with physicians to adjust system settings anywhere with cellular or Wi-Fi connection and a charged controller. The new system is also unique because of its 10-year battery life when used for low-dose treatment. This approval by the FDA now provides patients with DPN the ability to receive low doses of stimulation for symptoms contributing to chronic pain. The spinal cord stimulation system was first approved in 2019 to treat patients with chronic pain. " spinal cord stimulation system provides patients with painful the opportunity to obtain a better quality of life while more seamlessly fitting into their current lifestyles," Pope said in the press release. The therapy can be used with the NeuroSphere Virtual Clinic app (Abbott) to facilitate communication with physicians and health care providers and receive virtual treatment adjustments. The spinal cord stimulation system is implanted in the patient and then managed via an Apple device. ![]() While symptom management and behavior modifications aim to manage nerve damage and reduce worsening symptoms, SCS is considered a more effective treatment, despite it being a non-opioid. There are about 34.2 million (10.5%) people in the United States living with diabetes, and estimates suggest that 50% of these patients will develop DPN.ĭPN is caused by high blood sugar (glucose) levels that lead to nerve damage, resulting in pain and numbness in the legs, feet, and hands. Pope, MD, DABPM, FIPP, president of Evolve Restorative Center in Santa Rosa, California, in a press release.ĭiabetic neuropathy is a complication that mainly affects the nerves that connect to the feet. " has long plagued people affected by type 1 and type 2 diabetes, often adding another area of disease management on top of their ongoing monitoring of their glucose levels to manage this challenging disease," said Jason E. SCS, which is a form of neurostimulation therapy that doses tissue with a certain quantity of energy to relieve pain, can now be added to the available chronic pain management strategies that avoid the use of opioids for patients with DPN. The FDA approved a spinal cord stimulation (SCS) system (Proclaim XR Abbott) for diabetic peripheral neuropathy (DPN), a condition that currently has no disease modifying treatments.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |